Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
